{
  "title": "ADVN Biomarker Registry Study: CMI/Ab-Vaccinia Substudy",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY7",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "ADVN Biomarker Registry Study: CMI/Ab-Vaccinia Substudy",
  "performedBy": [
    {
      "firstName": "Donald",
      "lastName": "Leung",
      "email": "leungd@njhealth.org",
      "affiliations": [
          {
             "name": "National Jewish Health"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "firstName": "Jon",
      "lastName": "Hanifin",
      "email": "hanifinj@ohsu.edu",
      "affiliations": [
          {
             "name": "Oregon Health & Science University"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "Lynda",
      "lastName": "Schneider",
      "email": "lynda.schneider@childrens.harvard.edu",
      "affiliations": [
          {
             "name": "Children's Hospital Boston"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "Richard",
      "lastName": "Gallo",
      "email": "RGallo@ucsd.edu",
      "affiliations": [
          {
             "name": "University of California at San Diego"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    },
    {
      "firstName": "Lisa",
      "lastName": "Beck",
      "email": "Lisa_Beck@URMC.ROCHESTER.EDU",
      "affiliations": [
          {
             "name": "University of Rochester Medical Center"
          }
      ],
      "roles": [
          {
             "value": "None"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "AD+ EV+ with vaccination",
          "size": 7
        },
        {
          "name": "AD+ EV- with vaccination",
          "size": 29
        },
        {
          "name": "Healthy controls with vaccination",
          "size": 30
        },
        {
          "name": "AD+ no vaccination",
          "size": 24
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "Sign the informed consent form."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "1 to 80 years of age."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Residing in the U.S."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "No systemic disorders (i.e., immunodeficiency disorders such as human immunodeficiency virus [HIV] or lupus erythematosus) other than the condition being studied."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Meet the criteria for one of the diagnostic groups; ADEV+; subjects with a history of or active AD with no adverse events following smallpox vaccination (AD and no EV despite the smallpox vaccination [ADEV-]; age-matched to the ADEV+ group) and NA subjects with no adverse events following smallpox vaccination (age-matched to ADEV group) as confirmed by an ADVN investigator or co-investigator.  The standardized definitions for ADEV+, ADEV-, and NA Control have been developed for use in all ADVN studies and will be used to determine eligibility."
          ]
        },
        {
          "category": "Inclusion",
          "values": [
              "Subjects must be enrolled in the ADVN Biomarker Registry Study prior to the CMI/Ab-Vaccinia Substudy."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Unable or unwilling to complete the informed consent process."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Has atopy but lacks stringent AD features (only presumptive diagnosis of AD)."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "History of any systemic illness other than the condition being studied."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Has autoimmune or immunodeficiency disease.  Presence of active systemic malignancy, excluding uncomplicated non-melanoma skin cancer. "
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Presence of any skin disease other than AD that might compromise the stratum corneum barrier (e.g., bullous disease, psoriasis, cutaneous T cell lymphoma [also called Mycosis Fungoides or Sezary syndrome])."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Receiving an experimental new drug as part of a separate clinical trial.  If it is a Food and Drug Administration (FDA) approved drug the subject will be allowed to enroll and the information will be captured in their medication history."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Subjects receiving systemic immunosuppressives, oral corticosteroids, or immunomodulatory medicaion within 12 days of enrollment."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Subjects receiving immunotherapy within the last year."
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Subjects using topical medications including (but not restricted to) Elidel, Protopic, topical corticosteroids, or topical antibiotics at the site of the blood draw within the last 72 hours."
          ]
        }
  ],
  
  "types": [
      {
          "value": "Observational"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Donald",
      "lastName": "Leung",
      "email": "leungd@njhealth.org",
      "affiliations": [
          {
             "name": "National Jewish Health"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Atopic Dermatitis & Vaccinia Network (ADVN) Clinical Studies Consortium",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "N01 AI040029"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "The Atopic Dermatitis and Vaccinia Network (ADVN) is a consortium of academic medical centers that will conduct clinical research studies in an attempt to make smallpox vaccines safer for millions of people with atopic dermatitis.  http://projectreporter.nih.gov/project_info_description.cfm?aid=7337882&icde=23823696&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Clinical Trial"
      },
      {
        "value": "Observational"
      },
      {
        "value": "Atopy/Allergy"
      }
  ],
  "dates": [
      {
          "date": "2008-04-01",
          "type": {
              "value": "actual_start_date"
          }
      },
      {
          "date": "2012-11-16",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Skin/Integument exam"
        }
      },{
        "name": {
            "value": "Medical History"
        }
      },{
        "name": {
            "value": "Question about medications taken"
        }
      },{
        "name": {
            "value": "Any Adverse Event?"
        }
      },{
        "name": {
            "value": "Vaccination history"
        }
      },{
        "name": {
            "value": "Smallpox vaccination status"
        }
      },{
        "name": {
            "value": "Rajka-Langeland Score"
        }
      },{
        "name": {
            "value": "Physical Exam"
        }
      },{
        "name": {
            "value": "Interim Skin Infection History"
        }
      },{
        "name": {
            "value": "Interim Medical History"
        }
      },{
        "name": {
            "value": "Family History"
        }
      },{
        "name": {
            "value": "EASI Score"
        }
      }
      
  ],
  
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY7",
              "identifierSource": "ImmPort"
          },
          "title": "ADVN Biomarker Registry Study: CMI/Ab-Vaccinia Substudy",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY7",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Atopic Dermatitis & Vaccinia Network (ADVN) Clinical Studies Consortium",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "http://projectreporter.nih.gov/project_info_details.cfm?aid=6358320&icde=23811074&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "To measure total and specific antibody titers and T cell responses in a sample of subjects who experienced eczema vaccinatum (EV) and a group of subjects who did not suffer from EV (normal controls or healthy AD subjects)."
}
